Omniose
PrivateLast Round
Grant
Sep 27, 2023
Total Funding Raised
$12.7M
Company Overview
Omniose is a biotechnology company that develops polysaccharide conjugate vaccines against bacterial threats using its proprietary bioconjugation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniose Comparables
Compare Omniose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LimmaTech Biologics | 88% | |
| Glycovax Pharma | 81% | |
| Baxiva AG | 78% | |
Omniose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 27, 2023 | ||||
| Grant | Oct 11, 2022 | ||||
| Grant | Aug 20, 2020 | ||||
| Grant | Feb 21, 2020 | ||||
| Seed | Jan 1, 2019 | ||||
Grant | Nov 3, 2017 |
Key People
Founding team and executive leadership
Omniose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Arch Grants | Grant |
| NIH RADx | Grant |
| BioGenerator Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2023
$3M raised from National Institute of Allergy and Infectious Diseases
Omniose Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Omniose's valuation, stock price, and market status.